|
|
Volumn 94, Issue , 1998, Pages 23-33
|
|
Interferon use in solid tumors.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
BIOLOGICAL RESPONSE MODIFIER;
FLUOROURACIL;
FOLINIC ACID;
CANCER STAGING;
CLINICAL TRIAL;
COLORECTAL TUMOR;
DIGESTIVE SYSTEM TUMOR;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NEOPLASM;
PATHOLOGY;
REVIEW;
SURVIVAL;
TREATMENT FAILURE;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOLOGICAL RESPONSE MODIFIERS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
COLORECTAL NEOPLASMS;
COMBINED MODALITY THERAPY;
DIGESTIVE SYSTEM NEOPLASMS;
FLUOROURACIL;
HUMANS;
INTERFERON-ALPHA;
LEUCOVORIN;
LUNG NEOPLASMS;
NEOPLASM STAGING;
NEOPLASMS;
SURVIVAL ANALYSIS;
TREATMENT FAILURE;
|
|
EID: 0031632226
PISSN: 09273042
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-4615-6189-7_2 Document Type: Review |
|
Times cited : (6)
|
|
References (45)
|
